LIGHT/TNFSF14 is increased in patients with type 2 diabetes mellitus and promotes islet cell dysfunction and endothelial cell inflammation in vitro.
Halvorsen B, Santilli F, Scholz H, Sahraoui A, Gulseth HL, Wium C, Lattanzio S, Formoso G, Di Fulvio P, Otterdal K, Retterstøl K, Holven KB, Gregersen I, Stavik B, Bjerkeli V, Michelsen AE, Ueland T, Liani R, Davi G, Aukrust P.
Halvorsen B, et al. Among authors: lattanzio s.
Diabetologia. 2016 Oct;59(10):2134-44. doi: 10.1007/s00125-016-4036-y. Epub 2016 Jul 15.
Diabetologia. 2016.
PMID: 27421726
Free PMC article.